{"id":144824,"date":"2021-10-06T17:20:00","date_gmt":"2021-10-06T17:20:00","guid":{"rendered":"https:\/\/icrowdnewswire.com\/?p=2925970"},"modified":"2021-10-06T17:20:00","modified_gmt":"2021-10-06T17:20:00","slug":"3d-bioprinting-market-size-trends-scope-demand-opportunity-and-forecast-2021-to-2026","status":"publish","type":"post","link":"https:\/\/ipsnews.net\/business\/2021\/10\/06\/3d-bioprinting-market-size-trends-scope-demand-opportunity-and-forecast-2021-to-2026\/","title":{"rendered":"3D Bioprinting Market Size, Trends, Scope, Demand, Opportunity and Forecast 2021 to 2026"},"content":{"rendered":"

According to IMARC Group latest report titled” 3D Bioprinting Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026<\/strong>”, the market is currently witnessing strong growth. The Global 3D Bioprinting Market<\/strong><\/a> to exhibit moderate growth during the next five years. 3D bioprinting represents an additive manufacturing technique used for developing precise anatomical tissues through the decomposition of cell-based bio-inks. It involves several processes, including direct and laser writing, microstamping, stereolithography, electro-printing, photolithography, inkjet deposition, etc. The bio-inks are produced using living cells, biomaterials, active biomolecules, etc., to generate 3D structures of the tissues and organs. The printer deposits numerous layers of biomaterials to build complex bodily structures, such as bones, vascular grafts, skin, tracheal splints, cartilages, etc. 3D bioprinting assembles and binds these components with dissolvable gel or collagen scaffolds to support and mold the cells into the desired shape.<\/p>\n

Request to get the sample report:<\/strong> https:\/\/www.imarcgroup.com\/3d-bioprinting-market\/requestsample <\/a> <\/strong><\/p>\n

As the novel coronavirus (COVID-19<\/strong>) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.<\/em><\/p>\n

\"3D<\/em><\/p>\n

Market Trends:<\/strong><\/p>\n

The escalating incidences of chronic respiratory and cardiovascular disorders (CVDs) are primarily driving the 3D bioprinting market. Moreover, the growing requirement for regenerative medicines, cancer therapeutics, stem cell solutions, etc., is further bolstering the market growth. Besides this, 3D bioprinting is gaining traction for liver modeling and the development of various bone, tissue, and medical implants, which is acting as another significant growth-inducing factor. Additionally, the rising awareness among individuals regarding the importance of minimizing animal testing is augmenting the global market. In line with this, several cosmetic manufacturers are using bio-printed hair follicles and skin grafts to clinically test their products on human-like tissues instead of animals, which is also fueling the market growth. Furthermore, numerous technological advancements, including the development of organ-on-a-chip, magnetic levitation technology, 3D in-vitro analysis of the bodily functions, fabrication of artificial organs and tissues for tissue engineering and regenerative medicine, etc., are expected to propel the 3D bioprinting market in the coming years.<\/p>\n

View Full Report with TOC & List of Figure:<\/strong> https:\/\/www.imarcgroup.com\/3d-bioprinting-market<\/a><\/p>\n

Competitive Landscape with Key players:<\/strong><\/p>\n

The report has also analysed the competitive landscape of the market with some of the key players being.<\/p>\n